EGFR and non-small cell lung carcinoma: The cell line A549 was chosen for this study not only because it has the lowest RBM5 expression in seven different lung cancer cell lines[17], but also because it has wild-type EGFR-positive expression and gene amplification[39, 40], which are more common in NSCLC.